Target intelligence / Profile preview

SUMO1 pseudogene 2 (SUMO1P2)

Target
SUMO1P2
Molecular classification
Other (Pseudogene, non-coding DNA derived from SUMO1)
01

Overview

SUMO1 pseudogene 2 (SUMO1P2) is a genomic DNA sequence derived from the SUMO1 gene but lacks the capacity to encode a functional protein. It is categorized as a pseudogene, meaning it is an inactive copy and does not participate in cellular processes attributed to SUMO1 or other SUMO paralogues. Pseudogenes like SUMO1P2 do not have well-defined biological activities but sometimes are studied for potential regulatory effects on their parent genes or as indicators in genomics research[4][5][6]. Note: - The active gene/protein "Small ubiquitin-like modifier 1 (SUMO1)" is involved in post-translational modification (sumoylation), impacting gene expression, nuclear transport, transcriptional regulation, cell cycle, and apoptosis[1][3][5][6]. - SUMO1P2, as a pseudogene, does not share these functional roles and is not itself a therapeutic target or biomarker.

Other names
SUMO1P2SUMO1 pseudogene 2
02

Biological functions

Other (No known active biological functions; pseudogenes generally do not encode functional proteins and serve no canonical regulatory or catalytic activity[4].)
03

Disease associations

Other (No direct disease association; pseudogenes sometimes play minor regulatory roles or are implicated as genomic markers, but SUMO1P2 itself has no established clinical relevance[4].)

Beyond the preview

Go deeper on SUMO1 pseudogene 2 (SUMO1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUMO1 pseudogene 2 (SUMO1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call